A Fucosylated Lactose-Presenting Tetravalent Glycocluster Acting as a Mutual Ligand of <i>Pseudomonas aeruginosa</i> Lectins A (PA-IL) and B (PA-IIL)—Synthesis and Interaction Studies
The Gram-negative bacterium <i>Pseudomonas aeruginosa</i> is an important opportunistic human pathogen associated with cystic fibrosis. <i>P. aeruginosa</i> produces two soluble lectins, the <span style="font-variant: small-caps;">d</span>-galactose-spec...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/24/16194 |
Summary: | The Gram-negative bacterium <i>Pseudomonas aeruginosa</i> is an important opportunistic human pathogen associated with cystic fibrosis. <i>P. aeruginosa</i> produces two soluble lectins, the <span style="font-variant: small-caps;">d</span>-galactose-specific lectin PA-IL (LecA) and the <span style="font-variant: small-caps;">l</span>-fucose-specific lectin PA-IIL (LecB), among other virulence factors. These lectins play an important role in the adhesion to host cells and biofilm formation. Moreover, PA-IL is cytotoxic to respiratory cells in the primary culture. Therefore, these lectins are promising therapeutic targets. Specifically, carbohydrate-based compounds could inhibit their activity. In the present work, a 3-<i>O</i>-fucosyl lactose-containing tetravalent glycocluster was synthesized and utilized as a mutual ligand of galactophilic and fucophilic lectins. Pentaerythritol equipped with azido ethylene glycol-linkers was chosen as a multivalent scaffold and the glycocluster was constructed by coupling the scaffold with propargyl 3-<i>O</i>-fucosyl lactoside using an azide-alkyne 1,3-dipolar cycloaddition reaction. The interactions between the glycocluster and PA-IL or PA-IIL were investigated by isothermal titration microcalorimetry and saturation transfer difference NMR spectroscopy. These results may assist in the development of efficient anti-adhesion therapy for the treatment of a <i>P. aeruginosa</i> infection. |
---|---|
ISSN: | 1661-6596 1422-0067 |